speb/financial-data huggingface dataset:
Financial ratios for CCCM.V — quarterly report dated 2025-02-28
Total revenue: 0
Operating income: -651375
Net income: -600163.1944444445
Capital expenditures: 610364.5833333334
Operating cash flow: -403718.75
Depreciation & amortization: 1661.111111111111
Net tangible assets: 45330588.88888889
Owner earnings: -1208866.6666666667
Return on net tangible assets (%): -2.6667790917734484
Buffett classification: The Gruesome
Stock price: 0.4444444444444445
Shares outstanding: 125339801
Book value: 45330588.888888896
P/B ratio: 1.2288959748298487
Market cap (USD): 55706578.222222224
Debt to equity: 0
Current ratio: 3.638163431098612
Quick ratio: 3.638163431098612
Free cash flow (dilution-adjusted): -1014083.3333333334
Buyback yield (%): 0
Retained earnings: -16678099.305555556
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.436943609086138
Rule of 40 score: 0
Financial ratios for CCCM.V — quarterly report dated 2025-05-31
Total revenue: 0
Operating income: -863934.7826086957
Net income: -788207.2463768116
Capital expenditures: 775121.7391304348
Operating cash flow: -807352.1739130436
Depreciation & amortization: 1562.3188405797102
Net tangible assets: 53748803.623188406
Owner earnings: -1561766.6666666667
Return on net tangible assets (%): -2.905677078164558
Buffett classification: The Gruesome
Stock price: 0.4347826086956522
Shares outstanding: 125339801
Book value: 53748803.623188406
P/B ratio: 1.0138935562960762
Market cap (USD): 54495565.65217392
Debt to equity: 0
Current ratio: 11.073780264343407
Quick ratio: 11.073780264343407
Free cash flow (dilution-adjusted): -1983602.8985507246
Buyback yield (%): 0
Retained earnings: -18191441.304347828
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6073563025986597
Rule of 40 score: 0
Financial ratios for CCCM.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -474427.73722627736
Net income: -347596.35036496347
Capital expenditures: 932298.5401459853
Operating cash flow: -115002.91970802919
Depreciation & amortization: 1440.1459854014597
Net tangible assets: 54235486.861313865
Owner earnings: -1278454.7445255474
Return on net tangible assets (%): -2.357229221145737
Buffett classification: The Gruesome
Stock price: 0.7080291970802919
Shares outstanding: 125339801
Book value: 54235486.861313865
P/B ratio: 1.6362762427331463
Market cap (USD): 88744238.66423357
Debt to equity: 0
Current ratio: 9.970773327323547
Quick ratio: 9.970773327323547
Free cash flow (dilution-adjusted): -1179910.9489051094
Buyback yield (%): 0
Retained earnings: -18671821.897810217
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8747551920008416
Rule of 40 score: 0
Financial ratios for CCCM.V — annual report dated 2025-08-31
Total revenue: 0
Operating income: -2385307.299270073
Net income: -2118343.0656934306
Capital expenditures: 2181533.5766423354
Operating cash flow: -1756377.3722627736
Depreciation & amortization: 6782.481751824817
Net tangible assets: 54235486.861313865
Owner earnings: -4293094.160583941
Return on net tangible assets (%): -7.9156552453596625
Buffett classification: The Gruesome
Stock price: 0.7080291970802919
Shares outstanding: 125339801
Book value: 54235486.861313865
P/B ratio: 1.6362762427331463
Market cap (USD): 88744238.66423357
Debt to equity: 0
Current ratio: 9.970773327323547
Quick ratio: 9.970773327323547
Free cash flow (dilution-adjusted): -4474577.372262773
Buyback yield (%): 0
Retained earnings: -18671821.897810217
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.398056396856116
Rule of 40 score: 0
Financial ratios for CCCM.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -582853.5714285715
Net income: -474818.5714285715
Capital expenditures: 1353703.5714285716
Operating cash flow: -636006.4285714286
Depreciation & amortization: 1666.4285714285716
Net tangible assets: 54221827.14285715
Owner earnings: -1826855.7142857146
Return on net tangible assets (%): -3.369225661600327
Buffett classification: The Gruesome
Stock price: 0.9071428571428573
Shares outstanding: 125339801
Book value: 54221827.14285714
P/B ratio: 2.0969618912562864
Market cap (USD): 113701105.19285716
Debt to equity: 0
Current ratio: 8.22701606554351
Quick ratio: 8.22701606554351
Free cash flow (dilution-adjusted): -2118067.142857143
Buyback yield (%): 0
Retained earnings: -18746530
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.074942697694305
Rule of 40 score: 0
Financial ratios for CCCM.V — quarterly report dated 2026-02-28
Total revenue: 0
Operating income: -787237.2262773722
Net income: -682388.3211678831
Capital expenditures: 2902772.2627737224
Operating cash flow: -458278.10218978097
Depreciation & amortization: 4102.919708029197
Net tangible assets: 73764831.38686131
Owner earnings: -3581057.6642335765
Return on net tangible assets (%): -4.854695112705727
Buffett classification: The Gruesome
Stock price: 0.8832116788321167
Shares outstanding: 125339801
Book value: 73764831.38686131
P/B ratio: 1.5007365160928319
Market cap (USD): 110701576.06569342
Debt to equity: 0
Current ratio: 21.696550779332625
Quick ratio: 21.696550779332625
Free cash flow (dilution-adjusted): -3490777.3722627736
Buyback yield (%): 0
Retained earnings: -19839426.27737226
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0672256839423775
Rule of 40 score: 0
Financial ratios for CELU — annual report dated 2021-12-31
Capital expenditures: 6203000
Buffett classification: The Gruesome
Stock price: 51.2
Shares outstanding: 28945961
Market cap (USD): 1482033203.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELU — annual report dated 2022-12-31
Total revenue: 17975000
Gross profit: -1690000
Operating income: -148267000
Net income: 14192000
Capital expenditures: 5236000
Operating cash flow: -137876000
Depreciation & amortization: 9436000
Net tangible assets: -41787000
Owner earnings: 18392000
Return on net tangible assets (%): -44.01368846770527
Buffett classification: The Gruesome
Stock price: 12.9
P/E ratio: 26.310801641770013
Shares outstanding: 28945961
Book value: 198901000
P/B ratio: 1.8773304151311458
Market cap (USD): 373402896.90000004
Debt to equity: 0.3297519871694964
Current ratio: 0.5395889704934931
Quick ratio: 0.4540974101275609
Effective tax rate (%): 0.09151707145371349
COGS to revenue (%): 109.40194714881781
R&D to revenue (%): 435.95549374130735
SG&A to revenue (%): 367.2934631432545
Free cash flow (dilution-adjusted): -158968000
Buyback yield (%): 0
Retained earnings: -645496000
Inventory turnover: 3.7047852298417485
Receivables turnover: 2.580390467987367
Capitalized R&D asset: 78363000
ROCI (R&D-adjusted, %): -23.008762618578093
FCF margin (%): -884.3838664812239
Rule of 40 score: -884.3838664812239
Financial ratios for CELU — annual report dated 2023-12-31
Total revenue: 22771000
Gross profit: 6755000
Operating income: -76479000
Net income: -196295000
Capital expenditures: 4048000
Operating cash flow: -38685000
Depreciation & amortization: 9324000
Net tangible assets: 22612000
Owner earnings: -191019000
Return on net tangible assets (%): -844.7682646382452
Buffett classification: The Gruesome
Stock price: 2.47
Shares outstanding: 28945961
Book value: 40960000
P/B ratio: 1.7455205974121095
Market cap (USD): 71496523.67
Debt to equity: 1.5970947265625
Current ratio: 0.2941097803798033
Quick ratio: 0.20862432761746263
Interest coverage ratio: -25.366169154228857
COGS to revenue (%): 70.33507531509376
R&D to revenue (%): 133.7885907513943
SG&A to revenue (%): 222.10706600500635
Free cash flow (dilution-adjusted): -57750000
Buyback yield (%): 0
Retained earnings: -841791000
Inventory turnover: 2.783938814531549
Receivables turnover: 1.879105462947681
Capitalized R&D asset: 82968210
ROCI (R&D-adjusted, %): -51.573331304410445
Rosenberg metric: 0.10776769648941464
FCF margin (%): -253.61205041500153
Revenue growth (%): 26.681502086230875
Rule of 40 score: -226.93054832877067
Financial ratios for CELU — quarterly report dated 2024-09-30
Capital expenditures: 35000
Buffett classification: The Gruesome
Stock price: 2.97
Shares outstanding: 28945961
Market cap (USD): 85969504.17
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELU — annual report dated 2024-12-31
Total revenue: 54220000
Gross profit: 39231000
Operating income: -38551000
Net income: -57892000
Capital expenditures: 161000
Operating cash flow: -6401000
Depreciation & amortization: 7922000
Net tangible assets: -7758000
Owner earnings: -50131000
Buffett classification: The Gruesome
Stock price: 2.08
Shares outstanding: 28945961
Book value: 8837000
P/B ratio: 6.81312649994342
Market cap (USD): 60207598.88
Debt to equity: 7.78952133076836
Current ratio: 0.3830290611028316
Quick ratio: 0.28226527570789867
Interest coverage ratio: -6.154374201787995
COGS to revenue (%): 27.644780523791958
R&D to revenue (%): 32.06565842862412
SG&A to revenue (%): 108.15750645518258
Free cash flow (dilution-adjusted): -18131000
Buyback yield (%): 0
Retained earnings: -899683000
Inventory turnover: 2.7711222037345165
Receivables turnover: 3.9994098989451943
Capitalized R&D asset: 63657340
ROCI (R&D-adjusted, %): -44.32680911977676
Rosenberg metric: 1.0660101756113574
FCF margin (%): -33.43969015123571
Revenue growth (%): 138.10987659742656
Rule of 40 score: 104.67018644619085
Financial ratios for CELU — quarterly report dated 2024-12-31
Total revenue: 18132000
Gross profit: 10789000
Operating income: -9473000
Net income: -13293000
Capital expenditures: 56000
Operating cash flow: 1594000
Depreciation & amortization: 1876000
Net tangible assets: -7758000
Owner earnings: -11473000
Buffett classification: The Gruesome
Stock price: 2.08
Shares outstanding: 28945961
Book value: 8837000
P/B ratio: 6.81312649994342
Market cap (USD): 60207598.88
Debt to equity: 7.78952133076836
Current ratio: 0.3830290611028316
Quick ratio: 0.28226527570789867
Interest coverage ratio: -5.227924944812362
COGS to revenue (%): 40.49746304875359
R&D to revenue (%): 21.111846459298476
SG&A to revenue (%): 88.5616589455107
Free cash flow (dilution-adjusted): -1561000
Buyback yield (%): 0
Retained earnings: -899683000
Inventory turnover: 1.357552227768534
Receivables turnover: 1.337464040716973
Capitalized R&D asset: 3828000
ROCI (R&D-adjusted, %): -8.355668236146323
FCF margin (%): -8.609088903595854
Rule of 40 score: -8.609088903595854
Financial ratios for CELU — quarterly report dated 2025-03-31
Total revenue: 11426000
Gross profit: 7872000
Operating income: -10486000
Net income: -19754000
Capital expenditures: 0
Operating cash flow: -2993000
Depreciation & amortization: 1834000
Net tangible assets: -21733000
Owner earnings: -17920000
Buffett classification: The Gruesome
Stock price: 1.73
Shares outstanding: 28945961
Book value: -5506000
Market cap (USD): 50076512.53
Debt to equity: -12.672720668361787
Current ratio: 0.37621400579315045
Quick ratio: 0.27062531947520874
Interest coverage ratio: -4.302831350020517
COGS to revenue (%): 31.104498512165236
R&D to revenue (%): 32.62734115175915
SG&A to revenue (%): 124.82058463154209
Free cash flow (dilution-adjusted): -5630000
Buyback yield (%): 0
Retained earnings: -919501000
Inventory turnover: 0.5735033080522833
Receivables turnover: 0.7633618385889899
Capitalized R&D asset: 6292760
ROCI (R&D-adjusted, %): -12.129729439476614
Rosenberg metric: -0.7620167189132706
FCF margin (%): -49.27358655697532
Revenue growth (%): -36.984337083609084
Rule of 40 score: -86.25792364058441
Financial ratios for CELU — quarterly report dated 2025-06-30
Total revenue: 5736000
Gross profit: 494000
Operating income: -15864000
Net income: -24524000
Capital expenditures: 0
Operating cash flow: -999000
Depreciation & amortization: 1834000
Net tangible assets: -41352000
Owner earnings: -22690000
Buffett classification: The Gruesome
Stock price: 1.96
Shares outstanding: 28945961
Book value: -25497000
Market cap (USD): 56734083.56
Debt to equity: -2.7514609561909245
Current ratio: 0.24936802114781806
Quick ratio: 0.18566455284787728
Interest coverage ratio: -8.164693772516726
COGS to revenue (%): 91.38772663877266
R&D to revenue (%): 58.43793584379359
SG&A to revenue (%): 220.25801952580198
Free cash flow (dilution-adjusted): -3447000
Buyback yield (%): 0
Retained earnings: -944025000
Inventory turnover: 1.1886621315192745
Receivables turnover: 0.5143472022955524
Capitalized R&D asset: 7113000
ROCI (R&D-adjusted, %): -27.760490983169728
Rosenberg metric: -1.979077253218884
FCF margin (%): -60.09414225941423
Revenue growth (%): -49.79870470855943
Rule of 40 score: -109.89284696797365
Financial ratios for CELU — quarterly report dated 2025-09-30
Total revenue: 5284000
Gross profit: 1380000
Operating income: -12900000
Net income: -23076000
Capital expenditures: 0
Operating cash flow: -4159000
Depreciation & amortization: 1824000
Net tangible assets: -35573000
Owner earnings: -21252000
Buffett classification: The Gruesome
Stock price: 2.07
Shares outstanding: 28945961
Book value: -20094000
Market cap (USD): 59918139.269999996
Debt to equity: -3.3224843236787103
Current ratio: 0.1622316808035031
Quick ratio: 0.12299047677373917
Interest coverage ratio: -8.733920108327691
COGS to revenue (%): 73.88342165026495
R&D to revenue (%): 87.01741105223316
SG&A to revenue (%): 176.11657834973505
Free cash flow (dilution-adjusted): -6200000
Buyback yield (%): 0
Retained earnings: -967101000
Inventory turnover: 1.5232149824424503
Receivables turnover: 0.78806860551827
Capitalized R&D asset: 8074080
ROCI (R&D-adjusted, %): -21.394497361477878
Rosenberg metric: 0.26431980906921243
FCF margin (%): -117.33535200605603
Revenue growth (%): -7.880055788005579
Rule of 40 score: -125.2154077940616
Financial ratios for CLPS — annual report dated 2021-06-30
Total revenue: 16245063.530927835
Gross profit: 5176667.010309278
Operating income: 1079276.5463917525
Net income: 904538.0154639175
Capital expenditures: 138194.4587628866
Operating cash flow: -336310.95360824745
Depreciation & amortization: 87273.32474226804
Net tangible assets: 6854845.103092784
Owner earnings: 853616.881443299
Return on net tangible assets (%): 12.452752303012103
Capex to operating income (%): 12.804360404652506
Buffett classification: The Great
Stock price: 3.48
P/E ratio: 114.80950459195223
Shares outstanding: 29841828
Book value: 7439522.551546393
P/B ratio: 13.959170191427626
Market cap (USD): 103849561.44
Debt to equity: 0.13071872770629211
Current ratio: 3.304442749439115
Quick ratio: 3.304442749439115
Effective tax rate (%): 15.108828117676184
COGS to revenue (%): 68.13390726078859
R&D to revenue (%): 10.580464757045585
SG&A to revenue (%): 16.291962697978363
Free cash flow (dilution-adjusted): -1136260.1804123712
Buyback yield (%): 0
Retained earnings: 351309.92268041236
Receivables turnover: 2.821110895404231
Capitalized R&D asset: 1718803.2216494845
ROCI (R&D-adjusted, %): 23.643019586796417
FCF margin (%): -6.994495147705179
Rule of 40 score: -6.994495147705179
Financial ratios for CLPS — annual report dated 2022-06-30
Total revenue: 19365908.407643314
Gross profit: 5221533.248407643
Operating income: 943382.8025477708
Net income: 584447.2611464969
Capital expenditures: 2643255.796178344
Operating cash flow: 407756.56050955417
Depreciation & amortization: 116209.9363057325
Net tangible assets: 8053374.267515924
Owner earnings: -1942598.5987261147
Return on net tangible assets (%): -24.121548734693445
Capex to operating income (%): 280.189101289505
Buffett classification: The Gruesome
Stock price: 1.25
P/E ratio: 63.82489487045411
Shares outstanding: 29841828
Book value: 8637019.108280256
P/B ratio: 4.318884158104795
Market cap (USD): 37302285
Debt to equity: 0.21348429069949232
Current ratio: 2.5263784795538746
Quick ratio: 2.5263784795538746
Effective tax rate (%): 39.63967621873455
COGS to revenue (%): 73.03749899825604
R&D to revenue (%): 5.243402285614773
SG&A to revenue (%): 17.858377050416017
Free cash flow (dilution-adjusted): -3151994.777070064
Buyback yield (%): 0
Retained earnings: 805578.5987261147
Receivables turnover: 2.8075589746671543
Capitalized R&D asset: 2167030.6425815877
ROCI (R&D-adjusted, %): 9.289624420064225
Rosenberg metric: 0.02610318478185563
FCF margin (%): -16.275997545387742
Revenue growth (%): 19.211035221708563
Rule of 40 score: 2.935037676320821
Financial ratios for CLPS — annual report dated 2023-06-30
Total revenue: 19178129.974489797
Gross profit: 4398179.846938776
Operating income: 313638.9030612245
Net income: 24557.270408163266
Capital expenditures: 46035.33163265306
Operating cash flow: 1238003.9540816327
Depreciation & amortization: 155588.26530612246
Net tangible assets: 8144748.469387755
Owner earnings: 134110.20408163266
Return on net tangible assets (%): 1.6465849692681032
Capex to operating income (%): 14.677812982806742
Buffett classification: The Great
Stock price: 1
P/E ratio: 1215.193199569935
Shares outstanding: 29841828
Book value: 8355714.4132653065
P/B ratio: 3.5714274715545473
Market cap (USD): 29841828
Debt to equity: 0.1735802338986482
Current ratio: 2.7694098582242392
Quick ratio: 2.7694098582242392
Effective tax rate (%): 87.61742411446302
COGS to revenue (%): 77.06669079420617
R&D to revenue (%): 5.544819703518181
SG&A to revenue (%): 16.58848505418178
Free cash flow (dilution-adjusted): 855659.948979592
Buyback yield (%): 0
Retained earnings: 641456.7602040817
Receivables turnover: 3.074352229339033
Capitalized R&D asset: 2310937.5570673766
ROCI (R&D-adjusted, %): 1.0002644057810688
Rosenberg metric: -0.8108401241641708
FCF margin (%): 4.461644331943555
Revenue growth (%): -0.9696340042556711
Rule of 40 score: 3.492010327687884
Financial ratios for CLPS — annual report dated 2024-06-30
Total revenue: 18285880.409731116
Gross profit: 4218582.71446863
Operating income: -325021.1267605634
Net income: -236531.3700384123
Capital expenditures: 270007.8104993598
Operating cash flow: 1142795.6466069142
Depreciation & amortization: 160370.42253521128
Net tangible assets: 7526372.215108835
Owner earnings: -346168.7580025608
Return on net tangible assets (%): -4.599410554099935
Buffett classification: The Gruesome
Stock price: 0.81
Shares outstanding: 29841828
Book value: 8184329.449423816
P/B ratio: 2.9534344663632432
Market cap (USD): 24171880.680000003
Debt to equity: 0.4104065367229304
Current ratio: 1.9619256834696865
Quick ratio: 1.9619256834696865
COGS to revenue (%): 76.92983537055373
R&D to revenue (%): 5.010722223732358
SG&A to revenue (%): 20.791812348711836
Free cash flow (dilution-adjusted): 466060.947503201
Buyback yield (%): 0
Retained earnings: -6623.303457106274
Receivables turnover: 3.3731317810027317
Capitalized R&D asset: 1963820.522067272
ROCI (R&D-adjusted, %): -3.71579219329137
Rosenberg metric: -0.16889069059093606
FCF margin (%): 2.5487476515223157
Revenue growth (%): -4.652432567437627
Rule of 40 score: -2.103684915915311
Financial ratios for CLPS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 7366174.4845360825
Buffett classification: The Gruesome
Stock price: 1.17
Shares outstanding: 29841828
Book value: 8074725.644329897
P/B ratio: 4.323978336591213
Market cap (USD): 34914938.76
Debt to equity: 0.5051135997391377
Current ratio: 1.737693865611
Quick ratio: 1.737693865611
Buyback yield (%): 0
Retained earnings: -83787.75773195876
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.06
Shares outstanding: 1239950537
Market cap (USD): 18673655087.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNH — annual report dated 2022-12-31
Total revenue: 28374698795.180725
Gross profit: 8137349397.590362
Operating income: 4983132530.120482
Net income: 2456626506.0240965
Capital expenditures: 1203614457.8313253
Operating cash flow: 671084337.3493977
Depreciation & amortization: 644578313.2530121
Net tangible assets: 2983132530.120482
Owner earnings: 1897590361.4457834
Return on net tangible assets (%): 63.610662358642976
Capex to operating income (%): 24.153771760154736
Buffett classification: The Great
Stock price: 14.58
P/E ratio: 7.359066909490829
Shares outstanding: 1239950537
Book value: 8404819277.108429
P/B ratio: 2.150965801096876
Market cap (USD): 18078478829.46
Debt to equity: 3.3242545871559654
Current ratio: 5.268110795454545
Quick ratio: 4.413884943181818
Effective tax rate (%): 27.85234899328859
Interest coverage ratio: 5.6348773841961854
COGS to revenue (%): 71.3218122372723
R&D to revenue (%): 3.6771262366778483
SG&A to revenue (%): 7.439174557343637
Free cash flow (dilution-adjusted): -532530120.48192775
Buyback yield (%): 1.0196507744733547
Retained earnings: 9525301204.819277
Inventory turnover: 3.4913739347329034
Receivables turnover: 1.1936644703497212
Capitalized R&D asset: 1043373493.9759036
ROCI (R&D-adjusted, %): 13.616447590158408
FCF margin (%): -1.8767780561334977
Rule of 40 score: -1.8767780561334977
Financial ratios for CNH — annual report dated 2023-12-31
Total revenue: 31249367088.607594
Gross profit: 9935443037.974684
Operating income: 6259493670.886076
Net income: 2894936708.8607593
Capital expenditures: 1512658227.8481011
Operating cash flow: 1148101265.8227847
Depreciation & amortization: 713924050.6329113
Net tangible assets: 3954430379.746835
Owner earnings: 2096202531.6455693
Return on net tangible assets (%): 53.00896286811779
Capex to operating income (%): 24.165824064711828
Buffett classification: The Great
Stock price: 11.37
P/E ratio: 4.869964017706646
Shares outstanding: 1239950537
Book value: 10316455696.202538
P/B ratio: 1.3665776329441832
Market cap (USD): 14098237605.689999
Debt to equity: 3.3896932515337403
Current ratio: 2.0249742238515296
Quick ratio: 1.7073547943636154
Effective tax rate (%): 21.97558268590455
Interest coverage ratio: 3.676579925650558
COGS to revenue (%): 68.20593834811845
R&D to revenue (%): 4.216794264187628
SG&A to revenue (%): 7.546481954064893
Free cash flow (dilution-adjusted): -364556962.0253164
Buyback yield (%): 5.854039907535022
Retained earnings: 12220253164.556961
Inventory turnover: 3.036609558160505
Receivables turnover: 0.9969711654955173
Capitalized R&D asset: 2016781759.9511971
ROCI (R&D-adjusted, %): 17.644232386282813
Rosenberg metric: 1.7233460987517175
FCF margin (%): -1.1666059059423988
Revenue growth (%): 10.13109712345251
Rule of 40 score: 8.96449121751011
Financial ratios for CNH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.79
Shares outstanding: 1239950537
Market cap (USD): 13379066294.23
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNH — annual report dated 2024-12-31
Total revenue: 24795000000
Gross profit: 8107500000
Operating income: 4812500000
Net income: 1573750000
Capital expenditures: 1482500000
Operating cash flow: 2460000000
Depreciation & amortization: 756250000
Net tangible assets: 3557500000
Owner earnings: 847500000
Return on net tangible assets (%): 23.82290934645116
Capex to operating income (%): 30.80519480519481
Buffett classification: The Good
Stock price: 11.02
P/E ratio: 8.682608367110404
Shares outstanding: 1239950537
Book value: 9710000000
P/B ratio: 1.4072353159361484
Market cap (USD): 13664254917.74
Debt to equity: 3.496910401647786
Current ratio: 8.081776880363453
Quick ratio: 6.876325088339223
Effective tax rate (%): 23.06108442004118
Interest coverage ratio: 2.3898199875853505
COGS to revenue (%): 67.30187537810043
R&D to revenue (%): 4.658197217180883
SG&A to revenue (%): 8.630772333131679
Free cash flow (dilution-adjusted): 977500000
Buyback yield (%): 6.421864970191395
Retained earnings: 12886250000
Inventory turnover: 2.7952261306532664
Receivables turnover: 0.8484900333647019
Capitalized R&D asset: 2382186670.733567
ROCI (R&D-adjusted, %): 9.385224425798564
Rosenberg metric: -1.3871998078770416
FCF margin (%): 3.9423270820729988
Revenue growth (%): -20.65439300036456
Rule of 40 score: -16.71206591829156
Financial ratios for CNH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.02
Shares outstanding: 1239950537
Market cap (USD): 13664254917.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNH — quarterly report dated 2025-03-31
Total revenue: 4971428571.428572
Gross profit: 1635064935.064935
Operating income: 894805194.8051947
Net income: 171428571.42857143
Capital expenditures: 342857142.85714287
Operating cash flow: 210389610.38961038
Depreciation & amortization: 194805194.8051948
Net tangible assets: 3922077922.077922
Owner earnings: 23376623.376623333
Return on net tangible assets (%): 0.5960264900662241
Capex to operating income (%): 38.31640058055153
Buffett classification: The Good
Stock price: 11.94
P/E ratio: 21.5906387255125
Shares outstanding: 1239950537
Book value: 10336363636.363632
P/B ratio: 1.432322810286544
Market cap (USD): 14805009411.779999
Debt to equity: 3.3036813670059066
Current ratio: 7.962477512207658
Quick ratio: 6.637368285787715
Effective tax rate (%): 29.01234567901235
Interest coverage ratio: 1.9033149171270718
COGS to revenue (%): 67.11076280041797
R&D to revenue (%): 4.806687565308254
SG&A to revenue (%): 10.083594566353186
Free cash flow (dilution-adjusted): -132467532.46753247
Buyback yield (%): 0.04386019834840336
Retained earnings: 13558441558.441559
Inventory turnover: 0.4982544608223429
Receivables turnover: 0.1633942291275397
Capitalized R&D asset: 238961038.96103895
ROCI (R&D-adjusted, %): 2.116471099521947
FCF margin (%): -2.664576802507837
Rule of 40 score: -2.664576802507837
Financial ratios for CNH — quarterly report dated 2025-06-30
Total revenue: 6453424657.534246
Gross profit: 2080821917.8082192
Operating income: 1127397260.2739725
Net income: 297260273.9726027
Capital expenditures: 345205479.4520548
Operating cash flow: 1057534246.5753425
Depreciation & amortization: 213698630.13698632
Net tangible assets: 3906849315.0684934
Owner earnings: 165753424.65753424
Return on net tangible assets (%): 4.242636746143058
Capex to operating income (%): 30.61968408262455
Buffett classification: The Good
Stock price: 12.84
P/E ratio: 33.969156832508894
Shares outstanding: 1239950537
Book value: 10731506849.315071
P/B ratio: 1.483572169186673
Market cap (USD): 15920964895.08
Debt to equity: 3.5351033954557054
Current ratio: 7.813242784380306
Quick ratio: 6.5481445549357264
Effective tax rate (%): 27.636363636363637
Interest coverage ratio: 2.286111111111111
COGS to revenue (%): 67.75631500742942
R&D to revenue (%): 4.6274676289535135
SG&A to revenue (%): 10.146465718531099
Free cash flow (dilution-adjusted): 712328767.1232877
Buyback yield (%): 0
Retained earnings: 14164383561.643835
Inventory turnover: 0.6119631901840491
Receivables turnover: 0.19751792377678085
Capitalized R&D asset: 458734033.09019744
ROCI (R&D-adjusted, %): 2.281232560890474
Rosenberg metric: 1.865396069088744
FCF margin (%): 11.037996179155169
Revenue growth (%): 29.810266099826787
Rule of 40 score: 40.848262278981956
Financial ratios for CNH — quarterly report dated 2025-09-30
Total revenue: 5944594594.594595
Gross profit: 1897297297.2972972
Operating income: 775675675.6756756
Net income: 108108108.1081081
Capital expenditures: 364864864.8648649
Operating cash flow: 890540540.5405406
Depreciation & amortization: 214864864.86486486
Net tangible assets: 3962162162.1621623
Owner earnings: -41891891.8918919
Return on net tangible assets (%): -1.057298772169168
Capex to operating income (%): 47.03832752613241
Buffett classification: The Good
Stock price: 10.75
P/E ratio: 23.10946372315659
Shares outstanding: 1239950537
Book value: 10590540540.540543
P/B ratio: 1.2586202018419035
Market cap (USD): 13329468272.75
Debt to equity: 3.498149802220236
Current ratio: 7.880922847928553
Quick ratio: 6.552964524931778
Effective tax rate (%): 1.9607843137254901
Interest coverage ratio: 1.5185185185185184
COGS to revenue (%): 68.08365537622187
R&D to revenue (%): 6.387815412593771
SG&A to revenue (%): 12.480109115708116
Free cash flow (dilution-adjusted): 525675675.6756757
Buyback yield (%): 0.5069036977693914
Retained earnings: 14081081081.081081
Inventory turnover: 0.5594993461610313
Receivables turnover: 0.18751864955880473
Capitalized R&D asset: 658669064.3676945
ROCI (R&D-adjusted, %): 1.5831216655943245
Rosenberg metric: -0.6145549218943717
FCF margin (%): 8.842918845192088
Revenue growth (%): -7.884651792526971
Rule of 40 score: 0.9582670526651169
Financial ratios for CNH — quarterly report dated 2025-12-31
Total revenue: 6968918918.918919
Gross profit: 2059459459.4594595
Operating income: 971621621.6216216
Net income: 120270270.27027027
Capital expenditures: 556756756.7567568
Operating cash flow: 1277027027.0270271
Depreciation & amortization: 221621621.62162164
Net tangible assets: 4090540540.5405407
Owner earnings: -214864864.8648649
Return on net tangible assets (%): -5.252725470763132
Capex to operating income (%): 57.3018080667594
Buffett classification: The Good
Stock price: 9.13
P/E ratio: 16.24054039067857
Shares outstanding: 1239950537
Book value: 10574324324.324326
P/B ratio: 1.0705883473583897
Market cap (USD): 11320748402.810001
Debt to equity: 3.4548242811501595
Current ratio: 2.226586316908898
Quick ratio: 1.896845090393478
Effective tax rate (%): 45.454545454545446
Interest coverage ratio: 1.882198952879581
COGS to revenue (%): 70.4479348458406
R&D to revenue (%): 6.631762652705062
SG&A to revenue (%): 8.978088035679658
Free cash flow (dilution-adjusted): 720270270.2702702
Buyback yield (%): 0.5371624617654831
Retained earnings: 14197297297.297297
Inventory turnover: 0.7811223392818748
Receivables turnover: 0.2192042846212701
Capitalized R&D asset: 815129026.2865607
ROCI (R&D-adjusted, %): 2.6659805827747554
Rosenberg metric: 0.42704626334519613
FCF margin (%): 10.335466356408766
Revenue growth (%): 17.231188906569663
Rule of 40 score: 27.56665526297843
Financial ratios for CNH — annual report dated 2025-12-31
Total revenue: 24452702702.7027
Gross profit: 7710810810.810811
Operating income: 3790540540.5405407
Net income: 689189189.1891892
Capital expenditures: 1618918918.9189188
Operating cash flow: 3429729729.7297297
Depreciation & amortization: 850000000
Net tangible assets: 4090540540.5405407
Owner earnings: -79729729.72972965
Return on net tangible assets (%): -1.9491245457548707
Capex to operating income (%): 42.70944741532976
Buffett classification: The Good
Stock price: 9.13
P/E ratio: 16.42618395701843
Shares outstanding: 1239950537
Book value: 10574324324.324326
P/B ratio: 1.0705883473583897
Market cap (USD): 11320748402.810001
Debt to equity: 3.4548242811501595
Current ratio: 2.226586316908898
Quick ratio: 1.896845090393478
Effective tax rate (%): 29.67741935483871
Interest coverage ratio: 1.8927125506072875
COGS to revenue (%): 68.46642718983145
R&D to revenue (%): 5.664548217739707
SG&A to revenue (%): 10.367504835589942
Free cash flow (dilution-adjusted): 1810810810.8108108
Buyback yield (%): 1.1936943594788514
Retained earnings: 14197297297.297297
Inventory turnover: 2.6637282304880667
Receivables turnover: 0.7691490266088583
Capitalized R&D asset: 2593833236.400958
ROCI (R&D-adjusted, %): 9.418390230800439
Rosenberg metric: -0.3434538434538433
FCF margin (%): 7.40536059684996
Revenue growth (%): -1.3805093659903143
Rule of 40 score: 6.024851230859645
Financial ratios for CRB.AX — annual report dated 2021-12-31
Capital expenditures: 364523.9130434783
Depreciation & amortization: 2855.7971014492755
Buffett classification: The Gruesome
Stock price: 0.021739130434782608
Shares outstanding: 1191865701
Market cap (USD): 25910123.93478261
Buyback yield (%): 0.5542123295539542
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRB.AX — annual report dated 2022-12-31
Operating income: -1020737.1621621621
Net income: -1005469.5945945946
Capital expenditures: 2487.837837837838
Depreciation & amortization: 2099.324324324324
Net tangible assets: 6573123.6486486485
Owner earnings: -1005858.108108108
Return on net tangible assets (%): -15.30258917790022
Buffett classification: The Gruesome
Stock price: 0.006756756756756757
Shares outstanding: 1191865701
Book value: 6573123.6486486485
P/B ratio: 1.2251628082538815
Market cap (USD): 8053146.628378379
Debt to equity: 0
Current ratio: 22.316401607334882
Quick ratio: 22.316401607334882
Free cash flow (dilution-adjusted): -681234.4594594595
Buyback yield (%): 0.010747855223329392
Retained earnings: -23510386.486486487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.52895117638648
Rule of 40 score: 0
Financial ratios for CRB.AX — annual report dated 2023-12-31
Operating income: -925923.287671233
Net income: -885197.9452054795
Capital expenditures: 0
Depreciation & amortization: 2126.7123287671234
Net tangible assets: 6657771.91780822
Owner earnings: -883071.2328767123
Return on net tangible assets (%): -13.263765172169265
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1191865701
Book value: 6657771.917808219
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 27.30453117422565
Quick ratio: 27.30453117422565
Free cash flow (dilution-adjusted): -736539.7260273973
Retained earnings: -24717644.520547945
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.907404745941685
Rule of 40 score: 0
Financial ratios for CRB.AX — annual report dated 2024-12-31
Operating income: -595200
Net income: -575538.5093167701
Capital expenditures: 0
Depreciation & amortization: 901.8633540372671
Net tangible assets: 5526414.906832298
Owner earnings: -574636.6459627328
Return on net tangible assets (%): -10.398000433378797
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1191865701
Book value: 5526414.906832297
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 8.493766594573685
Quick ratio: 8.493766594573685
Free cash flow (dilution-adjusted): -507132.91925465834
Retained earnings: -22990296.894409936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.770092547053519
Rule of 40 score: 0
Financial ratios for CRB.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5526414.906832298
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1191865701
Book value: 5526414.906832297
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 8.493766594573685
Quick ratio: 8.493766594573685
Retained earnings: -22990296.894409936
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRTM.L — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.02611111111111111
Shares outstanding: 101763526
Market cap (USD): 2657158.734444444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRTM.L — annual report dated 2022-06-30
Total revenue: 0
Gross profit: 0
Operating income: -594341.4634146342
Net income: -807003.6585365854
Capital expenditures: 0
Operating cash flow: -723623.1707317074
Depreciation & amortization: 0
Net tangible assets: 986093.9024390244
Owner earnings: -807003.6585365854
Return on net tangible assets (%): -81.83841889099267
Buffett classification: The Gruesome
Stock price: 0.022926829268292682
Shares outstanding: 101763526
Book value: 986093.9024390245
P/B ratio: 2.366017050273498
Market cap (USD): 2333114.9863414634
Debt to equity: 0
Current ratio: 7.9327261249887275
Quick ratio: 7.9327261249887275
Free cash flow (dilution-adjusted): -723623.1707317074
Buyback yield (%): 0
Retained earnings: -1440065.8536585367
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -60.272298808924596
Rule of 40 score: 0
Financial ratios for CRTM.L — annual report dated 2023-06-30
Total revenue: 0
Gross profit: -38292.40506329114
Operating income: -3127348.1012658225
Net income: -3146802.5316455695
Capital expenditures: 978912.658227848
Operating cash flow: -2162978.481012658
Depreciation & amortization: 38292.40506329114
Net tangible assets: 3248608.8607594934
Owner earnings: -4087422.7848101263
Return on net tangible assets (%): -125.82071157235366
Buffett classification: The Gruesome
Stock price: 0.028481012658227847
Shares outstanding: 101763526
Book value: 2976396.2025316455
P/B ratio: 0.9737709884479275
Market cap (USD): 2898328.2721518986
Debt to equity: 0.34266611606168873
Current ratio: 0.2904661344630343
Quick ratio: 0.2904661344630343
Interest coverage ratio: -63.05941958702366
Free cash flow (dilution-adjusted): -3427235.4430379746
Buyback yield (%): 0
Retained earnings: -4641554.4303797465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -105.07163322563646
Rule of 40 score: 0
Financial ratios for CRTM.L — annual report dated 2024-06-30
Total revenue: 0
Gross profit: -66591.13924050632
Operating income: -3274453.164556962
Net income: -3151410.1265822784
Capital expenditures: 627855.6962025316
Operating cash flow: -2791450.6329113925
Depreciation & amortization: 66591.13924050632
Net tangible assets: 622807.5949367088
Owner earnings: -3712674.6835443038
Return on net tangible assets (%): -596.119044425204
Buffett classification: The Gruesome
Stock price: 0.00721518987341772
Shares outstanding: 101763526
Book value: -24417.72151898686
Market cap (USD): 734243.162278481
Debt to equity: -150.94624157594907
Current ratio: 0.028599755998550358
Quick ratio: 0.028599755998550358
Interest coverage ratio: -16.30189939627683
Free cash flow (dilution-adjusted): -3419306.329113924
Buyback yield (%): 0
Retained earnings: -7792964.556962025
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRTM.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -841313.75
Buffett classification: The Gruesome
Stock price: 0.001375
Shares outstanding: 101763526
Book value: -1521370
Market cap (USD): 139924.84824999998
Debt to equity: -3.03446975423467
Current ratio: 0.022428131088812864
Quick ratio: 0.022428131088812864
Buyback yield (%): 0
Retained earnings: -9128896.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRTM.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1716989.0410958903
Buffett classification: The Gruesome
Stock price: 0.0010958904109589042
Shares outstanding: 101763526
Book value: -2595082.1917808214
Market cap (USD): 111521.67232876713
Debt to equity: -2.0216642648634675
Current ratio: 0.007011240659677666
Quick ratio: 0.007011240659677666
Buyback yield (%): 0
Retained earnings: -11516195.89041096
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRTM.L — annual report dated 2025-06-30
Total revenue: 0
Gross profit: -139089.04109589042
Operating income: -2018068.493150685
Net income: -3144219.178082192
Capital expenditures: 164001.3698630137
Operating cash flow: -743461.6438356164
Depreciation & amortization: 139089.04109589042
Net tangible assets: -1716989.0410958903
Owner earnings: -3169131.506849315
Buffett classification: The Gruesome
Stock price: 0.0010958904109589042
Shares outstanding: 101763526
Book value: -2595082.1917808214
Market cap (USD): 111521.67232876713
Debt to equity: -2.0216642648634675
Current ratio: 0.007011240659677666
Quick ratio: 0.007011240659677666
Interest coverage ratio: -5.53749638210939
Free cash flow (dilution-adjusted): -907463.0136986302
Buyback yield (%): 0
Retained earnings: -11516195.89041096
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTVA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.06
Shares outstanding: 668820000
Market cap (USD): 30137029200
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTVA — annual report dated 2022-12-31
Total revenue: 17455000000
Gross profit: 7019000000
Operating income: 1928000000
Net income: 1158000000
Capital expenditures: 73000000
Operating cash flow: 872000000
Depreciation & amortization: 1223000000
Net tangible assets: 6001000000
Owner earnings: 2308000000
Return on net tangible assets (%): 38.460256623896015
Capex to operating income (%): 3.7863070539419086
Buffett classification: The Great
Stock price: 56.58
P/E ratio: 32.67861450777202
Shares outstanding: 668820000
Book value: 25541000000
P/B ratio: 1.481611354293097
Market cap (USD): 37841835600
Debt to equity: 0.051172624407814886
Current ratio: 1.5631980640357408
Quick ratio: 0.9292628443782577
Effective tax rate (%): 14.726507713884992
Interest coverage ratio: 24.40506329113924
COGS to revenue (%): 59.78802635348038
R&D to revenue (%): 6.966485247780006
SG&A to revenue (%): 18.178172443425954
Free cash flow (dilution-adjusted): 267000000
Buyback yield (%): 2.642577940907285
Retained earnings: 250000000
Inventory turnover: 1.532227279400969
Receivables turnover: 3.061743553762498
Capitalized R&D asset: 1216000000
ROCI (R&D-adjusted, %): 8.276417850307242
FCF margin (%): 1.5296476654253794
Rule of 40 score: 1.5296476654253794
Financial ratios for CTVA — annual report dated 2023-12-31
Total revenue: 17226000000
Gross profit: 7306000000
Operating income: 2110000000
Net income: 747000000
Capital expenditures: 57000000
Operating cash flow: 1769000000
Depreciation & amortization: 1211000000
Net tangible assets: 4806000000
Owner earnings: 1901000000
Return on net tangible assets (%): 39.55472326258843
Capex to operating income (%): 2.7014218009478674
Buffett classification: The Great
Stock price: 46.68
P/E ratio: 41.79453493975903
Shares outstanding: 668820000
Book value: 25279000000
P/B ratio: 1.2350376834526682
Market cap (USD): 31220517600
Debt to equity: 0.09846117330590609
Current ratio: 1.562109712748583
Quick ratio: 0.8993178979729081
Effective tax rate (%): 13.906678865507777
Interest coverage ratio: 9.055793991416309
COGS to revenue (%): 57.58736793219552
R&D to revenue (%): 7.761523278764658
SG&A to revenue (%): 18.437246023452918
Free cash flow (dilution-adjusted): 1174000000
Buyback yield (%): 2.4214845176045383
Retained earnings: -41000000
Inventory turnover: 1.4378895492100305
Receivables turnover: 3.1388483965014577
Capitalized R&D asset: 2151720000
ROCI (R&D-adjusted, %): 7.4729293422440435
Rosenberg metric: 0.23601973684210525
FCF margin (%): 6.815279229072332
Revenue growth (%): -1.3119450014322545
Rule of 40 score: 5.503334227640078
Financial ratios for CTVA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 57.77
Shares outstanding: 668820000
Market cap (USD): 38637731400
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTVA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.13
Shares outstanding: 668820000
Market cap (USD): 37540866600
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTVA — annual report dated 2024-12-31
Total revenue: 16908000000
Gross profit: 7379000000
Operating income: 2096000000
Net income: 919000000
Capital expenditures: 5000000
Operating cash flow: 2145000000
Depreciation & amortization: 1227000000
Net tangible assets: 4505000000
Owner earnings: 2141000000
Return on net tangible assets (%): 47.52497225305217
Capex to operating income (%): 0.2385496183206107
Buffett classification: The Great
Stock price: 56.13
P/E ratio: 40.84969162132753
Shares outstanding: 668820000
Book value: 24030000000
P/B ratio: 1.5622499625468165
Market cap (USD): 37540866600
Debt to equity: 0.11248439450686641
Current ratio: 1.4535913730021182
Quick ratio: 0.930579626420181
Effective tax rate (%): 32.31372549019608
Interest coverage ratio: 8.995708154506438
COGS to revenue (%): 56.357937071208895
R&D to revenue (%): 8.291932812869646
SG&A to revenue (%): 18.9022947717057
Free cash flow (dilution-adjusted): 1548000000
Buyback yield (%): 2.6877376346980757
Retained earnings: 55000000
Inventory turnover: 1.7542341678939617
Receivables turnover: 2.9788583509513744
Capitalized R&D asset: 2699070000
ROCI (R&D-adjusted, %): 6.577530516009735
Rosenberg metric: 0.054599850411368736
FCF margin (%): 9.155429382540808
Revenue growth (%): -1.8460466736328804
Rule of 40 score: 7.309382708907927
Financial ratios for CTVA — quarterly report dated 2025-03-31
Total revenue: 4417000000
Gross profit: 2075000000
Operating income: 827000000
Net income: 656000000
Capital expenditures: 8000000
Operating cash flow: -2109000000
Depreciation & amortization: 296000000
Net tangible assets: 5235000000
Owner earnings: 944000000
Return on net tangible assets (%): 18.032473734479463
Capex to operating income (%): 0.9673518742442563
Buffett classification: The Great
Stock price: 62.18
P/E ratio: 15.84879100609756
Shares outstanding: 668820000
Book value: 24527000000
P/B ratio: 1.695569274676887
Market cap (USD): 41587227600
Debt to equity: 0.16646960492518448
Current ratio: 1.4447347792004182
Quick ratio: 0.9977353889034056
Effective tax rate (%): 14.923469387755103
Interest coverage ratio: 22.97222222222222
COGS to revenue (%): 53.022413402762055
R&D to revenue (%): 7.58433325786733
SG&A to revenue (%): 17.002490378084673
Free cash flow (dilution-adjusted): -2203000000
Buyback yield (%): 0.6492377962699297
Retained earnings: 587000000
Inventory turnover: 0.4563522992985191
Receivables turnover: 0.5325536532433084
Capitalized R&D asset: 335000000
ROCI (R&D-adjusted, %): 3.3906877145408956
FCF margin (%): -49.875481095766354
Rule of 40 score: -49.875481095766354
Financial ratios for CTVA — quarterly report dated 2025-06-30
Total revenue: 6456000000
Gross profit: 3524000000
Operating income: 1832000000
Net income: 1316000000
Capital expenditures: 17000000
Operating cash flow: 947000000
Depreciation & amortization: 301000000
Net tangible assets: 6808000000
Owner earnings: 1600000000
Return on net tangible assets (%): 23.501762632197416
Capex to operating income (%): 0.9279475982532752
Buffett classification: The Great
Stock price: 73.81
P/E ratio: 25.033267849898582
Shares outstanding: 668820000
Book value: 26151000000
P/B ratio: 1.8877138235631525
Market cap (USD): 49365604200
Debt to equity: 0.13877098390118925
Current ratio: 1.6817990752416982
Quick ratio: 1.2282471626733922
Effective tax rate (%): 23.392461197339244
Interest coverage ratio: 35.23076923076923
COGS to revenue (%): 45.41511771995043
R&D to revenue (%): 5.808550185873606
SG&A to revenue (%): 17.905824039653037
Free cash flow (dilution-adjusted): 829000000
Buyback yield (%): 0.5064254840012674
Retained earnings: 1532000000
Inventory turnover: 0.6793327154772938
Receivables turnover: 0.7442932902928291
Capitalized R&D asset: 599450000
ROCI (R&D-adjusted, %): 5.999349419222176
Rosenberg metric: 4.325373134328358
FCF margin (%): 12.840768277571252
Revenue growth (%): 46.16255376952682
Rule of 40 score: 59.003322047098074
Financial ratios for CTVA — quarterly report dated 2025-09-30
Total revenue: 2618000000
Gross profit: 974000000
Operating income: -270000000
Net income: -318000000
Capital expenditures: 1000000
Operating cash flow: 193000000
Depreciation & amortization: 300000000
Net tangible assets: 6279000000
Owner earnings: -19000000
Return on net tangible assets (%): -0.3025959547698678
Buffett classification: The Gruesome
Stock price: 67.14
P/E ratio: 27.149077871825877
Shares outstanding: 668820000
Book value: 25461000000
P/B ratio: 1.763661081654295
Market cap (USD): 44904574800
Debt to equity: 0.17175287694905936
Current ratio: 1.5775431861804223
Quick ratio: 1.0679462571976968
Interest coverage ratio: -5.869565217391305
COGS to revenue (%): 62.796027501909855
R&D to revenue (%): 13.407181054239878
SG&A to revenue (%): 27.92207792207792
Free cash flow (dilution-adjusted): 36000000
Buyback yield (%): 0.5567361479614767
Retained earnings: 834000000
Inventory turnover: 0.3096045197740113
Receivables turnover: 0.3363309352517986
Capitalized R&D asset: 712800000
ROCI (R&D-adjusted, %): -0.8392119205026244
Rosenberg metric: -6.8
FCF margin (%): 1.3750954927425516
Revenue growth (%): -59.44857496902106
Rule of 40 score: -58.07347947627851